» Articles » PMID: 34945687

Relationship Between Structure and Biological Activity of Various Vitamin K Forms

Overview
Journal Foods
Specialty Biotechnology
Date 2021 Dec 24
PMID 34945687
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin K is involved many biological processes, such as the regulation of blood coagulation, prevention of vascular calcification, bone metabolism and modulation of cell proliferation. Menaquinones (MK) and phylloquinone vary in biological activity, showing different bioavailability, half-life and transport mechanisms. Vitamin K1 and MK-4 remain present in the plasma for 8-24 h, whereas long-chain menaquinones can be detected up to 96 h after administration. Geometric structure is also an important factor that conditions their properties. -phylloquinone shows nearly no biological activity. An equivalent study for menaquinone is not available. The effective dose to decrease uncarboxylated osteocalcin was six times lower for MK-7 than for MK-4. Similarly, MK-7 affected blood coagulation system at dose three to four times lower than vitamin K1. Both vitamin K1 and MK-7 inhibited the decline in bone mineral density, however benefits for the occurrence of cardiovascular diseases have been observed only for long-chain menaquinones. There are currently no guidelines for the recommended doses and forms of vitamin K in the prevention of osteoporosis, atherosclerosis and other cardiovascular disorders. Due to the presence of isomers with unknown biological properties in some dietary supplements, quality and safety of that products may be questioned.

Citing Articles

Vitamin K Properties in Stroke and Alzheimer's Disease: A Janus Bifrons in Protection and Prevention.

Grimaldi L, Cavallaro R, De Angelis D, Fuso A, Sancesario G Molecules. 2025; 30(5).

PMID: 40076254 PMC: 11901974. DOI: 10.3390/molecules30051027.


Understanding the Genetic Architecture of Vitamin Status Biomarkers in the Genome-Wide Association Study Era: Biological Insights and Clinical Significance.

Reay W, Clarke E, Albinana C, Hwang L Adv Nutr. 2024; 15(12):100344.

PMID: 39551434 PMC: 11653147. DOI: 10.1016/j.advnut.2024.100344.


Vitamin K2 Protects Against SARS-CoV-2 Envelope Protein-Induced Cytotoxicity in Chronic Myeloid Leukemia Cells and Enhances Imatinib Activity.

Okabe S, Arai Y, Gotoh A Int J Mol Sci. 2024; 25(21).

PMID: 39519351 PMC: 11546361. DOI: 10.3390/ijms252111800.


An analysis of vitamin K status in Chinese healthy children aged 0-18 years.

Liu J, Chen L, Guo C, Feng Q, Cao R, Liu P BMC Pediatr. 2024; 24(1):703.

PMID: 39506667 PMC: 11539694. DOI: 10.1186/s12887-024-05195-y.


The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC-MS/MS.

Qi X, Chen N, Song Q, Chu Y, Wu H, Shan J Bioanalysis. 2024; 16(17-18):973-984.

PMID: 39140688 PMC: 11485696. DOI: 10.1080/17576180.2024.2383109.


References
1.
van Summeren M, Braam L, Lilien M, Schurgers L, Kuis W, Vermeer C . The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children. Br J Nutr. 2009; 102(8):1171-8. DOI: 10.1017/S0007114509382100. View

2.
Walther B, Karl J, Booth S, Boyaval P . Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements. Adv Nutr. 2013; 4(4):463-73. PMC: 3941825. DOI: 10.3945/an.113.003855. View

3.
Azuma K, Ouchi Y, Inoue S . Vitamin K: novel molecular mechanisms of action and its roles in osteoporosis. Geriatr Gerontol Int. 2013; 14(1):1-7. DOI: 10.1111/ggi.12060. View

4.
LOWENTHAL J, Vergel Rivera G . Comparison of the activity of the cis and trans isomer of vitamin K1 in vitamin K-deficient and coumarin anticoagulant-pretreated rats. J Pharmacol Exp Ther. 1979; 209(3):330-3. View

5.
Jiang Y, Yang J, Yang C, Meng F, Zhou Y, Yu B . Vitamin K4 induces tumor cytotoxicity in human prostate carcinoma PC-3 cells via the mitochondria-related apoptotic pathway. Pharmazie. 2013; 68(6):442-8. View